Sleep Apnea and Gout: The Link, and What CPAP Does to Uric Acid

Gout attacks disproportionately start at night, and so does the oxygen deprivation of sleep apnea. The two are connected, modestly but measurably — and unusually for a comorbidity page, there is evidence that treating the apnea moves the chemistry.

What the evidence shows

A 2026 meta-analysis in Sleep Medicine, registered in advance on PROSPERO, pooled 17 studies across two separate questions — four cohort and three non-cohort studies on whether apnea is associated with gout, plus two randomised controlled trials and eight non-randomised studies on what CPAP does to serum uric acid.

On risk: people with obstructive sleep apnea had a higher risk of gout, RR 1.29 (95% CI 1.11 to 1.48, p < 0.001).

On treatment: CPAP lowered serum uric acid with an effect size the authors describe as approaching moderate, Hedges's g = −0.49 (95% CI −0.79 to −0.18).

And the dose matters. The urate-lowering effect was enhanced by daily CPAP use of four hours or more, or by treatment lasting six months or longer. Baseline uric acid, age and adherence were the key modulators — patients with higher starting urate and younger patients responded better.

Evidence tier 2 for the association, which is a 29% relative increase from a modest number of cohort studies. Tier 2 for the CPAP effect too: two randomised trials inside a pool otherwise made of non-randomised studies is better than nothing and short of definitive.

Why would they be connected?

The mechanism is specific and it is the same one that keeps appearing across this site: intermittent hypoxia.

Repeated oxygen desaturation accelerates the breakdown of adenosine triphosphate — the cell's energy currency — and ATP degradation produces purines. Purine metabolism ends at uric acid. So a night of repeated desaturations is a night of raised purine turnover, and raised purine turnover means more urate for the kidneys to clear.

Note which measure the mechanism implicates. It is the depth and duration of oxygen dips rather than the count of breathing events, which is the same distinction that keeps carrying the signal in other outcomes. Hypoxic burden.

There is also a large shared confounder, and it should not be glossed over. Obesity raises the risk of both conditions independently, as do alcohol, metabolic syndrome and diuretic use. A meta-analysis adjusting for what the component studies adjusted for cannot fully separate these, and an RR of 1.29 is in the range where residual confounding is a live explanation for part of it.

What this means practically

If you have gout and snore, mention it. Gout is managed by rheumatology or primary care, and sleep is rarely part of that consultation. The 29% figure is enough to justify asking, particularly alongside witnessed pauses or unrefreshing sleep.

If you have apnea and raised urate, the CPAP finding is the actionable one. It will not replace urate-lowering therapy — nothing here suggests stopping allopurinol — but the effect was larger with good adherence, which is one more reason the four-hour threshold matters. Getting used to CPAP.

Attend to the shared drivers, because they pay twice. Weight, alcohol and metabolic health sit underneath both conditions, and alcohol in particular worsens apnea on the same night it provokes gout. Alcohol and snoring · Weight and snoring.

Do not read this as apnea causing your gout. An observational association of this size, with this much shared confounding, establishes that the two travel together and that one treatment shifts a biomarker of the other. That is worth knowing and it is not causation.

The line

No consumer product treats obstructive sleep apnea, and nothing sold for snoring affects uric acid. If you have witnessed breathing pauses, gasping arousals, morning headaches or sleepiness that more sleep does not fix, that is an assessment — the gout is a reason to take it seriously rather than a thing to treat with a mouthpiece. Snoring versus sleep apnea.